🇧🇷 Leustatin in Brazil

Leustatin (CLADRIBINE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Leustatin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Leustatin approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Leustatin in Brazil?

Marketing authorisation holder not available in our data.